Decoding 6 Analyst Evaluations For CareDx
Portfolio Pulse from Benzinga Insights
Six analysts have recently published ratings on CareDx (NASDAQ:CDNA), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $16.5 from $13.00, with a high estimate of $22.00 and a low estimate of $14.00. Analysts from firms like Craig-Hallum, Goldman Sachs, and Stephens & Co. have raised their price targets, reflecting positive sentiment towards the stock.
May 31, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx has received positive analyst ratings, with an average price target increase to $16.5. Analysts from Craig-Hallum, Goldman Sachs, and Stephens & Co. have raised their price targets, indicating a bullish outlook.
The increase in average price target and the positive ratings from multiple analysts suggest a bullish short-term outlook for CareDx. The raised price targets from reputable firms indicate confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100